REACH

Creo Medical Group plc

("Creo" the "Company" or the "Group")

Creo CTO & Founder wins inaugural Technology Innovator of the Year Award at European Microwave Week

Chris Hancock wins $25,000 prize for first advanced energy multimodality instrument designed for flexible endoscopy using combined bipolar RF and microwave energy for advanced endoscopic procedures

Creo Medical Group plc (AIM: CREO), a medical device company focused on the emerging field of surgical endoscopy, announces that its Chief Technology Officer (CTO) and Founder, Chris Hancock, has won an inaugural Technology Innovator of the Year Award at European Microwave Week.

The ceremony, sponsored by Junkosha, the pioneers of sophisticated fluoropolymer application technologies across Interventional Medical and Microwave and Millimeter Wave sectors, took place yesterday in London, UK, and saw Chairperson of the Awards, Joe Rowan, present Chris with the Award and the $25,000 prize.

Junkosha launched its Technology Innovator of the Year Award in March 2021 as part of a celebration of milestones including its new corporate image and website. The Award was designed to recognise the innovative work of an individual or team working in the delivery of products used within Interventional Medical procedures or Microwave/Millimeter Wave technologies. Its aim was to highlight the achievements of pioneers in advanced technology together with their contributions to society. Chris Hancock and Creo Medical were selected by a distinguished panel of judges following presentations completed by a shortlist of five candidates throughout February.

Chris Hancock is the founder and Chief Technology Officer of Creo Medical, with over 20 years' experience in medical device development including four years at Gyrus Group plc in his role as Senior Engineer. Chris holds a personal Chair in the Medical Microwave Systems Research Group at Bangor University and is a Fellow of the Institute of Physics, a Chartered Physicist, a Fellow of the Institute of Engineering and Technology, a Chartered Engineer and a Senior Member of the IEEE. 

Joe Rowan, Chairperson for the Award, and Junkosha's President and CEO of USA and Europe, explained: "We are very excited and proud to present Creo Medical and Chris Hancock as our first Technology Innovator of the Year Award winner. Chris' breakthrough technology holds the potential to transform the point of treatments for a range of cancers. Overall, Chris' achievement is one we can use as a yardstick to measure others in future years."

Mamoru Sogo, President and CEO of Junkosha Inc, said: "We believe that enabling innovators, like Creo Medical, is central to the philosophy behind the Junkosha brand as we continually look to advance the next generation of technology for a better future. As part of the plans to raise awareness of our new brand internationally, the Awards program delivers a tangible commitment to our values. We congratulate Chris Hancock and Creo Medical on their Award and look forward to observing their continued success well into the future."

Chris Hancock, Chief Technology Officer of Creo, commented: "I was delighted to be nominated for this accolade, even more to win it and have the work we are doing at Creo Medical recognised in this way. It is a real honour.

"Like most innovations - our products and the technology that powers them are all products of an idea. From the beginning in 2001 our idea has always been about harnessing advances in technology, together with creative and innovative thinking, to help patients and to offer a better alternative for treating cancer as well as other indications. I have been fortunate enough to see that belief materialise into something that is transforming lives every day, and which has the real potential to move the needle in how all manner of surgical procedures are conducted.

"I look forward to ensuring that this $25k prize is used to empower and encourage others with an idea or a passion to see it reach its potential. As we've said many times at Creo - anything is possible with the right approach."

For more information about our Technology Innovation of the Year Awards, click here: https://www.junkosha.com/en/news/54.

Enquiries:

About Creo Medical

Creo Medical is a medical device company focused on the development and commercialisation of minimally invasive electrosurgical devices, bringing advanced energy to endoscopy.

The Company's vision is to improve patient outcomes through the development and commercialisation of a suite of electrosurgical medical devices, each enabled by CROMA, powered by Kamaptive. The Group has developed the CROMA powered by Kamaptive full-spectrum adaptive technology to optimise surgical capability and patient outcomes. Kamaptive is a seamless, intuitive integration of multi-modal energy sources, optimised to dynamically adapt to patient tissue during procedures such as resection, dissection, coagulation and ablation of tissue. Kamaptive technology provides clinicians with increased flexibility, precision and controlled surgical solutions. CROMA currently delivers bipolar radiofrequency ("RF") energy for precise localised cutting and focused high frequency microwave ("MW") energy for controlled coagulation and ablation via a single accessory port. This technology, combined with the Group's range of patented electrosurgical devices, is designed to provide clinicians with flexible, accurate and controlled clinical solutions. The Directors believe the Company's technology can impact the landscape of surgery and endoscopy by providing a safer, less-invasive and more cost-efficient option for procedures.

For more information, please refer to the website www.creomedical.com

About Junkosha 

Junkosha are pioneers of sophisticated fluoropolymer application technologies across medical device and microwave interconnect sectors. With three operations in Japan, including its headquarters as well as sites in the US, UK and China, it is one of the best kept advanced technology secrets outside of Japan. The company provides tube and fitting products, including generic resin tubes, fluoropolymer tubes, high-barrier tubes, flexible multi-layered tubes, industrial hoses, degassing modules, heat-shrinkable tubes, and the market leading peelable heat shrink tubes. It also provides wire and cable products, including microwave interconnects, robot cables, high data rate cables, camera link cable assemblies, ultrafine coaxial cables and assemblies, cables for clean environments, and general wires and cables.